Index by author
Mandell, Brian F.
- You have accessSGLT-2 inhibitors: Diabetes and CKD and CHF (and gout?), oh my!Brian F. Mandell, MD, PhDCleveland Clinic Journal of Medicine July 2024, 91 (7) 392-393; DOI: https://doi.org/10.3949/ccjm.91b.07024
What mechanisms might account for the diverse beneficial effects of the SGLT-2 inhibitors observed across various diseases?
Marks, Lisa
- You have accessDo patients with sepsis benefit from intravenous albumin?Ryan Dunn, MD, Kealy Ham, MD, Lisa Marks, MLS, AHIP and Neera Agrwal, MD, PhDCleveland Clinic Journal of Medicine July 2024, 91 (7) 405-407; DOI: https://doi.org/10.3949/ccjm.91a.23089
Patients with sepsis who do not need vasopressors do not benefit from intravenous albumin compared with intravenous crystalloid therapy alone.
Mehdi, Ali
- You have accessIn Reply: Severe hyponatremia: Are you monitoring the urine output?Elias Bassil, MD, Georges N. Nakhoul, MD, MEd, Jonathan J. Taliercio, DO, FASN and Ali Mehdi, MD, MEd, FACP, FASNCleveland Clinic Journal of Medicine July 2024, 91 (7) 397-399; DOI: https://doi.org/10.3949/ccjm.91c.07002
Nakhoul, Georges N.
- You have accessIn Reply: Severe hyponatremia: Are you monitoring the urine output?Elias Bassil, MD, Georges N. Nakhoul, MD, MEd, Jonathan J. Taliercio, DO, FASN and Ali Mehdi, MD, MEd, FACP, FASNCleveland Clinic Journal of Medicine July 2024, 91 (7) 397-399; DOI: https://doi.org/10.3949/ccjm.91c.07002
O'shea, Robert S.
- You have accessDoes my patient with acute variceal hemorrhage need a transjugular intrahepatic portosystemic shunt?Mahnur Haider, MD, Indira Bhavsar-Burke, MD, Robert S. O’Shea, MD, MSCE and Christina C. Lindenmeyer, MDCleveland Clinic Journal of Medicine July 2024, 91 (7) 409-413; DOI: https://doi.org/10.3949/ccjm.91a.24014
Placement of a transjugular intrahepatic portosystemic shunt can be used as salvage therapy to control bleeding when endoscopic management fails and as a means of secondary prophylaxis in select patients.
Rakita, Val
- You have accessSGLT-2 inhibitors in heart failure and chronic kidney disease: A review for internistsCME articleRahul Jaswaney, MD, Samantha Sokoloff, MD, Val Rakita, MD and Daniel J. Rubin, MD, MScCleveland Clinic Journal of Medicine July 2024, 91 (7) 415-423; DOI: https://doi.org/10.3949/ccjm.91a.23093
This review summarizes recent data and guidelines regarding SGLT-2 inhibitors in heart failure and chronic kidney disease and provides practical guidance for their use.
Rubin, Daniel J.
- You have accessSGLT-2 inhibitors in heart failure and chronic kidney disease: A review for internistsCME articleRahul Jaswaney, MD, Samantha Sokoloff, MD, Val Rakita, MD and Daniel J. Rubin, MD, MScCleveland Clinic Journal of Medicine July 2024, 91 (7) 415-423; DOI: https://doi.org/10.3949/ccjm.91a.23093
This review summarizes recent data and guidelines regarding SGLT-2 inhibitors in heart failure and chronic kidney disease and provides practical guidance for their use.
Sokoloff, Samantha
- You have accessSGLT-2 inhibitors in heart failure and chronic kidney disease: A review for internistsCME articleRahul Jaswaney, MD, Samantha Sokoloff, MD, Val Rakita, MD and Daniel J. Rubin, MD, MScCleveland Clinic Journal of Medicine July 2024, 91 (7) 415-423; DOI: https://doi.org/10.3949/ccjm.91a.23093
This review summarizes recent data and guidelines regarding SGLT-2 inhibitors in heart failure and chronic kidney disease and provides practical guidance for their use.
Taliercio, Jonathan J.
- You have accessIn Reply: Severe hyponatremia: Are you monitoring the urine output?Elias Bassil, MD, Georges N. Nakhoul, MD, MEd, Jonathan J. Taliercio, DO, FASN and Ali Mehdi, MD, MEd, FACP, FASNCleveland Clinic Journal of Medicine July 2024, 91 (7) 397-399; DOI: https://doi.org/10.3949/ccjm.91c.07002